| 10224078
|
Identification and characterization of human rhinovirus-14 3C protease deamidation isoform. |
J Biol Chem |
1999 |
Cox GA;Johnson RB;Cook JA;Wakulchik M;Johnson MG;Villarreal EC;Wang QM |
View
More |
| 10353638
|
Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides. |
Bioorg Med Chem |
1999 |
Dragovich PS;Zhou R;Skalitzky DJ;Fuhrman SA;Patick AK;Ford CE;Meador JW 3rd;Worland ST |
View
More |
| 10486111
|
Evidence that enviroxime targets multiple components of the rhinovirus 14 replication complex. |
Arch Virol |
1999 |
Brown-Augsburger P;Vance LM;Malcolm SK;Hsiung H;Smith DP;Heinz BA |
View
More |
| 10549379
|
Update on influenza and rhinovirus infections. |
Adv Exp Med Biol |
1999 |
Hayden FG |
View
More |
| 10794684
|
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation. |
J Med Chem |
2000 |
Reich SH;Johnson T;Wallace MB;Kephart SE;Fuhrman SA;Worland ST;Matthews DA;Hendrickson TF;Chan F;Meador J 3rd;Ferre RA;Brown EL;DeLisle DM;Patick AK;Binford SL;Ford CE |
View
More |
| 10950388
|
Antiviral therapy for enteroviruses and rhinoviruses. |
Antivir Chem Chemother |
2000 |
Rotbart HA |
View
More |
| 11163466
|
Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention. |
Vaccine |
2000 |
Hayden FG |
View
More |
| 11825938
|
Role of picornaviruses in flu-like illnesses of adults enrolled in an oseltamivir treatment study who had no evidence of influenza virus infection. |
J Clin Microbiol |
2002 |
Boivin G;Osterhaus AD;Gaudreau A;Jackson HC;Groen J;Ward P |
View
More |
| 12719275
|
Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. |
Circulation |
2003 |
Pelat M;Dessy C;Massion P;Desager JP;Feron O;Balligand JL |
View
More |
| 14505664
|
Synthesis and evaluation of tripeptidyl alpha-ketoamides as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2003 |
Chen SH;Lamar J;Victor F;Snyder N;Johnson R;Heinz BA;Wakulchik M;Wang QM |
View
More |
| 15168800
|
Mode of action of 2-furylmercury chloride, an anti-rhinovirus compound. |
Antiviral Res |
2004 |
Verheyden B;Andries K;Rombaut B |
View
More |
| 15888438
|
Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. |
J Biol Chem |
2005 |
Grassme H;Riehle A;Wilker B;Gulbins E |
View
More |
| 16226325
|
Ceramide-enriched membrane domains. |
Biochim Biophys Acta |
2005 |
Bollinger CR;Teichgraber V;Gulbins E |
View
More |
| 16942941
|
Correlation between striatal dopamine D2/D3 receptor binding and cardiovascular activity in healthy subjects. |
Am J Hypertens |
2006 |
Yeh TL;Yang YK;Chiu NT;Yao WJ;Yeh SJ;Wu JS;Chuang JI;Chang SH |
View
More |
| 16957557
|
Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels? |
J Hypertens |
2006 |
Aw TJ;Liew D;Tofler GH;Schneider HG;Morel-Kopp MC;Billah B;Krum H |
View
More |
| 17595532
|
Infections with human rhinovirus induce the formation of distinct functional membrane domains. |
Cell Physiol Biochem |
2007 |
Dreschers S;Franz P;Dumitru C;Wilker B;Jahnke K;Gulbins E |
View
More |
| 18248816
|
New anti-viral drugs for the treatment of the common cold. |
Bioorg Med Chem |
2008 |
Maugeri C;Alisi MA;Apicella C;Cellai L;Dragone P;Fioravanzo E;Florio S;Furlotti G;Mangano G;Ombrato R;Luisi R;Pompei R;Rincicotti V;Russo V;Vitiello M;Cazzolla N |
View
More |
| 19237651
|
Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. |
Antimicrob Agents Chemother |
2009 |
De Palma AM;Thibaut HJ;van der Linden L;Lanke K;Heggermont W;Ireland S;Andrews R;Arimilli M;Al-Tel TH;De Clercq E;van Kuppeveld F;Neyts J |
View
More |
| 19272312
|
The autonomic phenotype of rumination. |
Int J Psychophysiol |
2009 |
Ottaviani C;Shapiro D;Davydov DM;Goldstein IB;Mills PJ |
View
More |
| 19780373
|
Short half-life hypnotics preserve physical fitness and altitude tolerance during military mountainous training. |
Mil Med |
2009 |
Jouanin JC;Dussault C;Van Beers P;Pierard C;Beaumont M |
View
More |
| 2160796
|
Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides. |
Antiviral Res |
1990 |
Ninomiya Y;Shimma N;Ishitsuka H |
View
More |
| 21824825
|
COX-2 inhibition does not reverse the increased sympathetic modulation in MSG obese rats. |
Auton Neurosci |
2011 |
da Cunha NV;Pinge-Filho P;Barbosa Neto O;Grassiolli S;Martins-Pinge MC |
View
More |
| 22945356
|
Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication. |
Cell Res |
2012 |
van der Schaar HM;van der Linden L;Lanke KH;Strating JR;Purstinger G;de Vries E;de Haan CA;Neyts J;van Kuppeveld FJ |
View
More |
| 23164665
|
Nickel-regulated heart rate variability: the roles of oxidative stress and inflammation. |
Toxicol Appl Pharmacol |
2013 |
Chuang HC;Hsueh TW;Chang CC;Hwang JS;Chuang KJ;Yan YH;Cheng TJ |
View
More |
| 23650168
|
Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. |
Antimicrob Agents Chemother |
2013 |
Spickler C;Lippens J;Laberge MK;Desmeules S;Bellavance E;Garneau M;Guo T;Hucke O;Leyssen P;Neyts J;Vaillancourt FH;Decor A;O'Meara J;Franti M;Gauthier A |
View
More |
| 24084488
|
Favipiravir (T-705), a novel viral RNA polymerase inhibitor. |
Antiviral Res |
2013 |
Furuta Y;Gowen BB;Takahashi K;Shiraki K;Smee DF;Barnard DL |
View
More |
| 24237854
|
Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle. |
Respir Res |
2013 |
Van Ly D;De Pedro M;James P;Morgan L;Black JL;Burgess JK;Oliver BG |
View
More |
| 24870364
|
A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases. |
J Med Chem |
2014 |
Kathman SG;Xu Z;Statsyuk AV |
View
More |
| 25525752
|
Sphingolipids in viral infection. |
Biol Chem |
2015 |
Schneider-Schaulies J;Schneider-Schaulies S |
View
More |
| 25889951
|
Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration. |
Respir Res |
2015 |
Schilter HC;Collison A;Russo RC;Foot JS;Yow TT;Vieira AT;Tavares LD;Mattes J;Teixeira MM;Jarolimek W |
View
More |
| 26116580
|
Secretion of Fc-amidated peptide fusion proteins by Chinese hamster ovary cells. |
BMC Biotechnol |
2015 |
Carlson KR;Pomerantz SC;Li J;Vafa O;Naso M;Strohl W;Mains RE;Eipper BA |
View
More |
| 26216863
|
Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA). |
Prog Neuropsychopharmacol Biol Psychiatry |
2016 |
Yeh TC;Kao LC;Tzeng NS;Kuo TB;Huang SY;Chang CC;Chang HA |
View
More |
| 26658373
|
Potent inhibition of enterovirus D68 and human rhinoviruses by dipeptidyl aldehydes and alpha-ketoamides. |
Antiviral Res |
2016 |
Kim Y;Kankanamalage AC;Damalanka VC;Weerawarna PM;Groutas WC;Chang KO |
View
More |
| 27063860
|
Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds. |
Antiviral Res |
2016 |
Smee DF;Evans WJ;Nicolaou KC;Tarbet EB;Day CW |
View
More |
| 28046097
|
Glucocorticoid Insensitivity in Virally Infected Airway Epithelial Cells Is Dependent on Transforming Growth Factor-beta Activity. |
PLoS Pathog |
2017 |
Xia YC;Radwan A;Keenan CR;Langenbach SY;Li M;Radojicic D;Londrigan SL;Gualano RC;Stewart AG |
View
More |
| 28088354
|
Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307. |
Antiviral Res |
2017 |
Albulescu L;Bigay J;Biswas B;Weber-Boyvat M;Dorobantu CM;Delang L;van der Schaar HM;Jung YS;Neyts J;Olkkonen VM;van Kuppeveld FJM;Strating JRPM |
View
More |
| 28281386
|
Effects of depression and melatonergic antidepressant treatment alone and in combination with sedative-hypnotics on heart rate variability: Implications for cardiovascular risk. |
World J Biol Psychiatry |
2018 |
Chang CC;Tzeng NS;Yeh CB;Kuo TBJ;Huang SY;Chang HA |
View
More |
| 28360114
|
RORalpha-dependent type 2 innate lymphoid cells are required and sufficient for mucous metaplasia in immature mice. |
Am J Physiol Lung Cell Mol Physiol |
2017 |
Rajput C;Cui T;Han M;Lei J;Hinde JL;Wu Q;Bentley JK;Hershenson MB |
View
More |
| 2843086
|
Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes. |
Antimicrob Agents Chemother |
1988 |
Wyde PR;Six HR;Wilson SZ;Gilbert BE;Knight V |
View
More |
| 2984980
|
Controlled trial of enviroxime against natural rhinovirus infections in a community. |
Antimicrob Agents Chemother |
1985 |
Miller FD;Monto AS;DeLong DC;Exelby A;Bryan ER;Srivastava S |
View
More |
| 2988431
|
Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4\',6-dichloroflavan, and enviroxime. |
Antimicrob Agents Chemother |
1985 |
Ninomiya Y;Aoyama M;Umeda I;Suhara Y;Ishitsuka H |
View
More |
| 2996687
|
Rhinovirus colds. |
Br Med Bull |
1985 |
Phillpotts RJ;Tyrrell DA |
View
More |
| 3002267
|
Antiviral agents against picornaviruses. |
Antiviral Res |
1985 |
Eggers HJ |
View
More |
| 3005577
|
Synthesis and antiviral activity of sulfonamidobenzophenone oximes and sulfonamidobenzamides. |
J Med Chem |
1986 |
Ogata M;Matsumoto H;Shimizu S;Kida S;Wada T;Shiro M;Sato K |
View
More |
| 30156431
|
Identification of a Novel Inhibitor of Human Rhinovirus Replication and Inflammation in Airway Epithelial Cells. |
Am J Respir Cell Mol Biol |
2019 |
Yang Z;Bochkov YA;Voelker DR;Foster MW;Que LG |
View
More |
| 3017203
|
Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds. |
Antiviral Res |
1986 |
Ahmad AL;Tyrrell DA |
View
More |
| 3025150
|
Molecular basis of drug resistance to new antirhinovirus agents. |
J Antimicrob Chemother |
1986 |
Ishitsuka H;Ninomiya Y;Suhara Y |
View
More |
| 31260948
|
Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [(11)C]PBR28 positron emission tomography. |
J Neuroimmunol |
2019 |
Forsberg A;Lampa J;Estelius J;Cervenka S;Farde L;Halldin C;Lekander M;Olgart Hoglund C;Kosek E |
View
More |
| 3228281
|
Small particle aerosols of enviroxime-containing liposomes. |
Antiviral Res |
1988 |
Gilbert BE;Six HR;Wilson SZ;Wyde PR;Knight V |
View
More |
| 3232968
|
Failure to demonstrate synergy between interferon-alpha and a synthetic antiviral, enviroxime, in rhinovirus infections in volunteers. |
Antiviral Res |
1988 |
Higgins PG;Barrow GI;al-Nakib W;Tyrrell DA;DeLong DC;Lenox-Smith I |
View
More |
| 32524861
|
Roflumilast counteracts DMH-induced preneoplastic colon damage in albino Wistar rats. |
Hum Exp Toxicol |
2020 |
Saeedan AS;Rastogi S;Ansari MN |
View
More |
| 33895135
|
Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells. |
J Biol Chem |
2021 |
Carpinteiro A;Gripp B;Hoffmann M;Pohlmann S;Hoertel N;Edwards MJ;Kamler M;Kornhuber J;Becker KA;Gulbins E |
View
More |
| 34285133
|
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. |
Science |
2021 |
Drayman N;DeMarco JK;Jones KA;Azizi SA;Froggatt HM;Tan K;Maltseva NI;Chen S;Nicolaescu V;Dvorkin S;Furlong K;Kathayat RS;Firpo MR;Mastrodomenico V;Bruce EA;Schmidt MM;Jedrzejczak R;Munoz-Alia MA;Schuster B;Nair V;Han KY;O'Brien A;Tomatsidou A;Meyer B;Vignuzzi M;Missiakas D;Botten JW;Brooke CB;Lee H;Baker SC;Mounce BC;Heaton NS;Severson WE;Palmer KE;Dickinson BC;Joachimiak A;Randall G;Tay S |
View
More |
| 34857794
|
Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease. |
Sci Rep |
2021 |
Sugiyama MG;Cui H;Redka DS;Karimzadeh M;Rujas E;Maan H;Hayat S;Cheung K;Misra R;McPhee JB;Viirre RD;Haller A;Botelho RJ;Karshafian R;Sabatinos SA;Fairn GD;Madani Tonekaboni SA;Windemuth A;Julien JP;Shahani V;MacKinnon SS;Wang B;Antonescu CN |
View
More |
| 35184710
|
Favipiravir in the Battle with Respiratory Viruses. |
Mini Rev Med Chem |
2022 |
Smyk JM;Majewska A |
View
More |
| 35907638
|
Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study. |
Thorax |
2022 |
Fujiogi M;Zhu Z;Raita Y;Ooka T;Celedon JC;Freishtat R;Camargo CA;Hasegawa K |
View
More |
| 4340949
|
Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. |
Science |
1972 |
Sidwell RW;Huffman JH;Khare GP;Allen LB;Witkowski JT;Robins RK |
View
More |
| 4355593
|
Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides. |
J Med Chem |
1973 |
Witkowski JT;Robins RK;Khare GP;Sidwell RW |
View
More |
| 4367686
|
Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection. |
Antimicrob Agents Chemother |
1973 |
Togo Y;Schwartz AR;Hornick RB |
View
More |
| 4373947
|
[Ambulatory treatment of virus related respiratory tract diseases. 1. Importance of virus related respiratory tract infections]. |
Z Arztl Fortbild (Jena) |
1974 |
Walther H;Dohner L;Meyer FP |
View
More |
| 6113314
|
The activity of enviroxime against rhinovirus infection in man. |
Lancet |
1981 |
Phillpotts RJ;Jones RW;Delong DC;Reed SE;Wallace J;Tyrrell DA |
View
More |
| 6245149
|
Inhibition of rhinovirus replication in in organ culture by a potential antiviral drug. |
J Infect Dis |
1980 |
DeLong DC;Reed SE |
View
More |
| 6247489
|
Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-am ine. Inhibitors of rhinovirus multiplication. |
J Med Chem |
1980 |
Wikel JH;Paget CJ;DeLong DC;Nelson JD;Wu CY;Paschal JW;Dinner A;Templeton RJ;Chaney MO;Jones ND;Chamberlin JW |
View
More |
| 6287928
|
Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. |
Antimicrob Agents Chemother |
1982 |
Hayden FG;Gwaltney JM Jr |
View
More |
| 6297380
|
Topical enviroxime against rhinovirus infection. |
Antimicrob Agents Chemother |
1982 |
Levandowski RA;Pachucki CT;Rubenis M;Jackson GG |
View
More |
| 6870216
|
Therapeutic activity of enviroxime against rhinovirus infection in volunteers. |
Antimicrob Agents Chemother |
1983 |
Phillpotts RJ;Wallace J;Tyrrell DA;Tagart VB |
View
More |
| 6927286
|
Antiviral activity of sodium 5-aminosulfonyl-2,4-dichlorobenzoate (M12325). |
Antimicrob Agents Chemother |
1982 |
Ohnishi H;Yamaguchi K;Shimada S;Himuro S;Suzuki Y |
View
More |
| 7769678
|
The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. |
J Virol |
1995 |
Heinz BA;Vance LM |
View
More |
| 7988393
|
Literature review: the common cold. |
Ear Nose Throat J |
1994 |
Hilding DA |
View
More |
| 8676522
|
Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses. |
J Virol |
1996 |
Heinz BA;Vance LM |
View
More |
| 9341923
|
Synthesis and antiviral activity of C2 analogs of enviroxime: an exploration of the role of critical functionality. |
J Med Chem |
1997 |
Victor F;Loncharich R;Tang J;Spitzer WA |
View
More |
